Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Keith

Showing results (641-650 of 918) with videos related to

Pageof 92
Sort By:
Blood|November 15, 2014
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myelomaShaji K Kumar, Betsy LaPlant, Wee Joo Chng, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
Genome-Wide Analysis of Innate Susceptibility Mechanisms of <i>Escherichia coli</i> to ColistinMuhammad Yasir, A Keith Turner, Sarah Bastkowski, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Bortezomib in relapsed or refractory Waldenström's macroglobulinemiaChristine Chen, C Tom Kouroukis, Darrell White, et al.
BMC Genomics|October 10, 2008
The unfoldomics decade: an update on intrinsically disordered proteinsA Keith Dunker, Christopher J Oldfield, Jingwei Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalanSuzanne Trudel, A Keith Stewart, Zhihua Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2014
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myelomaK Martin Kortuem, Kaitlyn Zidich, Steven R Schuster, et al.
BMC Genomics|August 25, 2016
Lipopolysaccharide treatment induces genome-wide pre-mRNA splicing pattern changes in mouse bone marrow stromal stem cellsAo Zhou, Meng Li, Bo He, et al.
European Journal of Pharmacology|August 3, 2010
In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligandJohn C Gordon, Eifion Phillips, David A Gurley, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 15, 2010
Inhibition of apoptosis by 60% oxygen: a novel pathway contributing to lung injury in neonatal ratsMan Yi, Azhar Masood, Adrian Ziino, et al.
Environmental Toxicology and Chemistry|November 21, 2007
Polycyclic aromatic hydrocarbon exposure in Steller's eiders (Polysticta stelleri) and Harlequin ducks (Histronicus histronicus) in the eastern Aleutian Islands, Alaska, USAA Keith Miles, Paul L Flint, Kimberley A Trust, et al.
Pageof 92

Showing results (641-650 of 918) with videos related to

Sort By:
Pageof 92
Blood|November 15, 2014
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myelomaShaji K Kumar, Betsy LaPlant, Wee Joo Chng, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
Genome-Wide Analysis of Innate Susceptibility Mechanisms of <i>Escherichia coli</i> to ColistinMuhammad Yasir, A Keith Turner, Sarah Bastkowski, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Bortezomib in relapsed or refractory Waldenström's macroglobulinemiaChristine Chen, C Tom Kouroukis, Darrell White, et al.
BMC Genomics|October 10, 2008
The unfoldomics decade: an update on intrinsically disordered proteinsA Keith Dunker, Christopher J Oldfield, Jingwei Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalanSuzanne Trudel, A Keith Stewart, Zhihua Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2014
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myelomaK Martin Kortuem, Kaitlyn Zidich, Steven R Schuster, et al.
BMC Genomics|August 25, 2016
Lipopolysaccharide treatment induces genome-wide pre-mRNA splicing pattern changes in mouse bone marrow stromal stem cellsAo Zhou, Meng Li, Bo He, et al.
European Journal of Pharmacology|August 3, 2010
In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligandJohn C Gordon, Eifion Phillips, David A Gurley, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 15, 2010
Inhibition of apoptosis by 60% oxygen: a novel pathway contributing to lung injury in neonatal ratsMan Yi, Azhar Masood, Adrian Ziino, et al.
Environmental Toxicology and Chemistry|November 21, 2007
Polycyclic aromatic hydrocarbon exposure in Steller's eiders (Polysticta stelleri) and Harlequin ducks (Histronicus histronicus) in the eastern Aleutian Islands, Alaska, USAA Keith Miles, Paul L Flint, Kimberley A Trust, et al.
Pageof 92